Dense humanoid robot catalysts in 2H26; sentiment may benefit, but mass-production pace still needs validation
AI summary card
Dense humanoid robot catalysts in 2H26; sentiment may benefit, but mass-production pace still needs validation
Morgan Stanley believes that Tesla Optimus Gen3, domestic OEM IPOs, commercial orders, and WAIC/WRC events will lift attention on China’s humanoid robot supply chain, but delays at leading U.S. players and slower-than-expected mass-production ramp-up remain the main risks.
- The Tesla Optimus Gen3 launch and production update are expected in 3Q26 and are a high-importance catalyst for China’s humanoid robot supply chain, but a delay would weigh on sector sentiment.
- Unitree has passed the Shanghai Stock Exchange listing committee review and is awaiting regulatory approval, while DeepRobotics and Leju have also submitted IPO applications; the wave of robot IPOs could lift market attention.
- Commercial validation in the industry is still progressing, and positive ROI, scaled deployment, or end-customer repeat purchases will be important proof points for the long-term investment case.
- Hengli is said to hold about 70% share of the body lead-screw product at the leading U.S. OEM, and its year-end capacity target supports about 100,000 robots; long-term screw+motor value per unit is around Rmb10–15k.
- LeaderDrive, Hengli, and Shuanghuan benefit from opportunities in harmonic reducers, lead screws/motors, and precision gears/new-type reducers respectively, but all face risks from penetration rates, market-share changes, and competition.
Report interpretation
Overview
This report focuses on the humanoid robot value chain within China Industrials and sorts out the catalyst events that may affect stock prices and market sentiment in 2H26. Core events include Tesla Optimus Gen3 launches and production progress, domestic OEM IPOs, real-world commercial orders, 2Q26 earnings and humanoid robot business commentary, as well as industry events such as WAIC, WRC, and the World Humanoid Robot Games.
Core views
The report’s central view is that the humanoid robot sector still has multiple high-visibility catalysts in 2H26, which should support investor attention and sentiment in the short term; however, the true long-term investment case will not be determined by a single product launch, but by commercial validation, order repeatability, scaled deployment, and changes in supply-chain share. Supplier feedback suggests that the leading U.S. humanoid robot player has been delayed, current volumes are still limited, and the probability of reaching 1,000 units per week in 4Q26 is not high, while expectations for 2027 are relatively more positive.
Analysis framework
The report uses a catalyst-event preview framework, ranking events by timing, importance, and potential surprise, and combines it with the supply relationships of key industrial-chain companies in reducers, lead screws, motors, and gears to assess the impact of events on stock sentiment, valuation, and risk. On valuation, the report uses P/E, P/S, and DCF methods to assess core business value and humanoid robot business potential respectively.
Methodology notes
Preview stock-price catalysts by event timing, importance, and potential surprise
The report maps events such as Tesla Optimus, domestic IPOs, commercial orders, earnings commentary, and industry exhibitions onto the 2H26 timeline to judge their potential impact on China’s humanoid robot supply-chain stocks.
Value core businesses and humanoid robot potential separately
For Shuanghuan, the report uses 25x 2026e P/E for the core business and applies 6x P/S to Rmb1.1bn of sales when global humanoid robot shipments exceed 1 million units to estimate the value of the humanoid robot business.
Long-term discounted cash flow valuation
For Hengli and LeaderDrive’s humanoid robot-related value, the report discounts 2025-50e cash flows using an 11% WACC and a 4% perpetual growth rate.
Overweight, Equal-weight, and Underweight indicate expected returns relative to the industry coverage portfolio
Morgan Stanley’s stock ratings are not direct buy, hold, or sell calls; they reflect the analyst’s expectation of risk-adjusted total return over the next 12-18 months relative to the industry coverage portfolio.
Asset mapping & comparison
Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).
- Jiangsu Hengli Hydraulic Co.Ltd (601100.SS)A beneficiary of the humanoid robot lead-screw, hydraulics, and related components supply chain
- Strengths
- It is said to hold about 70% share of the body lead-screw product at the leading U.S. OEM, and it has already entered the humanoid robot supply chains of Xiaomi, Xpeng, and Li Auto; capacity preparation in Mexico supports future ramp-up.
- Weaknesses
- Product launch and order timing still carry uncertainty, and the contribution from humanoid robots depends on customer production ramp-up.
- Comparison
- Compared with pure reducer names, Hengli’s appeal lies in the combined support from lead screws, motors, and its traditional hydraulics business.
- Risks
- Weakening demand for excavators and pumps/valves, failure to expand share in non-excavator components, and slower-than-expected humanoid robot penetration.
- Leader Harmonious Drive Systems (688017.SS)A core beneficiary of the harmonic reducer and bearing supply chain
- Strengths
- The company previously said it supplies harmonic reducers and bearings to the leading U.S. OEM; if its share increases, this could be an important upside catalyst.
- Weaknesses
- It is sensitive to solution-roadmap changes and customer share shifts, and would come under pressure if harmonic reducers are no longer the mainstream solution.
- Comparison
- Compared with Hengli and Shuanghuan, LeaderDrive has more direct exposure to the harmonic reducer route and OEM volume ramp-up.
- Risks
- Industrial robot demand below expectations, insufficient manufacturing capex, slower-than-expected humanoid robot development, and a decline in the standing of harmonic reducer solutions.
- Zhejiang Shuanghuan Driveline Co. Ltd. (002472.SZ)A beneficiary of gears, reducers, and precision transmission
- Strengths
- The company supplies gears for reducer production and has spent more than two years developing a new-type reducer with the leading U.S. humanoid robot OEM; its precision gear capabilities may migrate into humanoid robot components.
- Weaknesses
- The adoption cycle for the new-type reducer is relatively long, so monetization of the humanoid robot business may come later.
- Comparison
- Compared with LeaderDrive, Shuanghuan’s humanoid robot value comes more from the migration of precision gear capabilities into new-type reducers.
- Risks
- Share gains slower than expected, weaker-than-expected overseas demand, intensifying competition in China’s gear and actuator markets, and slower-than-expected progress in humanoid robot reducers.
- China humanoid robot supply chainA theme-driven equity asset set catalyzed by 2H26 events
- Strengths
- Tesla, domestic IPOs, industry exhibitions, commercial orders, and new product launches create dense catalysts that may lift investor attention.
- Weaknesses
- Current actual shipment volumes are still limited, and commercial value and scaled deployment remain to be validated.
- Comparison
- Compared with traditional industrial automation, the sector has higher upside, but it is also more sensitive to technology routes, commercial validation, and market sentiment.
- Risks
- Launch delays, slower-than-expected mass production, unclear commercial ROI, shifts in supply-chain share, and elevated valuations.
Key data
- Tesla Optimus Gen3 launch and production update3Q26; importance Very High; surprise In-lineTesla previously indicated that Optimus could be launched around July-August; a delay would be a downside risk for sector sentiment.
- Domestic OEM IPO updates3Q26; importance Very High; potential modest upside surpriseUnitree has passed the Shanghai Stock Exchange listing committee review and is awaiting regulatory approval; DeepRobotics and Leju have submitted IPO applications.
- Commercial orders and real-world validation3Q26; importance High to Very High; potential modest upside surprisePositive ROI, scaled deployment, or end-customer repeat purchases will validate the long-term investment case for humanoid robots.
- Major industry eventsWAIC 2026 in July; WRC 2026 on Aug 19-23; the second World Humanoid Robot Games on Aug 22-26Industry events and new product launches by OEMs may attract industrial and public attention and improve investor sentiment.
- Hengli supply-chain shareAbout 70% share of the body lead-screw product at the leading U.S. OEMMost capacity is being prepared in Mexico, and the year-end capacity target supports about 100,000 robots.
- Hengli per-robot valueLead screw ASP about Rmb1k; long-term screw+motor value about Rmb10–15k per unit; expected GPM 25-30%This data is used to gauge the long-term profit potential of the humanoid robot business.
- Hengli target priceRmb133Derived from 35x 2026e P/E on the core business plus DCF valuation for the humanoid robot components business.
- LeaderDrive valuationRmb269 per shareBased on DCF using 2025-50e cash flows, an 11% WACC, and a 4% perpetual growth rate.
- Shuanghuan valuation methodCore business 25x 2026e P/E; humanoid robot business 6x P/S applied to Rmb1.1bn salesUsed to reflect the longer adoption cycle and higher growth potential of the new-type reducer.
Impact & implications
For investors, the short-term trading focus is on 3Q26 catalyst realization and improved market sentiment, especially around Tesla Optimus, domestic IPOs, and industry exhibitions; in the medium term, greater attention should be paid to commercial orders, capacity ramp-up, customer onboarding, and supply-share changes. If OEM product launches, real orders, or supply-chain share come in above expectations, valuations of related component companies could be supported; if the leading U.S. player continues to delay, production scale remains insufficient, or the solution approach changes, the sector may face a pullback.
Risks
- A delay in the Tesla Optimus Gen3 launch or production update would weigh on sector sentiment.
- Supplier feedback suggests that the leading U.S. humanoid robot player has been delayed, and the probability of reaching 1,000 units per week in 4Q26 is not high.
- Commercial validation is insufficient; without positive ROI, scaled deployment, or repeat orders, the long-term investment case will be questioned.
- Changes in humanoid robot supply-chain share may create upside or downside risk for individual stocks, especially LeaderDrive’s share gains or losses.
- If harmonic reducers are no longer the mainstream technical solution, related valuations and earnings expectations could be affected.
- Intensifying competition in China’s gears, actuators, and robot components could compress margins.
- Weakening demand in traditional businesses, such as excavators, pumps/valves, overseas OEMs, or manufacturing capex below expectations.
What to watch
- Whether Tesla Optimus Gen3 is launched as scheduled in July-August or 3Q26, and whether production ramp-up targets are updated.
- Regulatory approval and listing timing for Unitree, as well as the subsequent IPO progress of DeepRobotics and Leju.
- 2Q26 earnings commentary on revenue, orders, customer onboarding, and capacity for the humanoid robot business.
- Evidence of real-world end-use orders, repeat purchases, positive ROI, and scaled deployment by OEMs.
- New product launches and market feedback during WAIC 2026, WRC 2026, and the World Humanoid Robot Games.
- Hengli’s lead-screw share at the leading U.S. OEM, Mexico capacity build-out, and progress with domestic OEM customers.
- LeaderDrive’s harmonic reducer and bearing share changes, and whether its technology route remains mainstream.
- Progress and commercialization timeline for Shuanghuan’s new-type reducer development with the leading U.S. OEM.